Dr. Reddy's Laboratories Ltd. plans to grow significantly in the U.S. private-label OTC drug market, with an eye toward chipping away at Perrigo Co. PLC’s lead in the segment.
The Indian firm predicts that by the end of its next fiscal year in March 2013 its U.S
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?